RA
DMTK

Royce & Associates’s DermTech, Inc. Common Stock DMTK Stock Holding History

Royce & Associates’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-262,100
Closed -$8.42M – 1030
2021
Q3 		$8.42M Buy
+262,100
New +$9.21M 0.06% 467

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Royce & Associates's DMTK Position: Q4 2021 in Review

Royce & Associates sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2021, closing a stake of 262,100 shares — an estimated $8.42M sold.

Royce & Associates first reported a position in DMTK in Q3 2021 and held it in 1 quarter. The position peaked at $8.42M in Q3 2021. 143 funds tracked by Wall St. Rank hold DMTK as of Q4 2021.

  • Royce & Associates reported no remaining DermTech, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Royce & Associates sold 262,100 DermTech, Inc. Common Stock shares in Q4 2021, an estimated $8.42M.
  • Royce & Associates first reported a position in DermTech, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Royce & Associates's DermTech, Inc. Common Stock position peaked at $8.42M in Q3 2021.
  • 143 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2021.

Based on Royce & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.